Antibody Therapeutics for Life

Press Release

Samsung Biologics enters into a development and manufacturing partnership with PharmAbcine for oncology and neovascular treatment
  • Written by PharmAbcine
  • Written date 2020-04-07 10:06:06
  • Inquire 16312

Prev PharmAbcine, Announces Acceptance of Phase Ib Olinvacimab and Pembrolizuamb Comb...
Next PharmAbcine to Present Preclinical Data of Blood Vessel Stabilizing PMC-402 at 2...